The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Amazon.com Inc. | Common | 023135106 | 1,848 | 1,000 | SH | DFND | 1,000 | 0 | 0 | ||
Capri Holdings Ltd | Common | G1890L107 | 3,147 | 82,500 | SH | DFND | 82,500 | 0 | 0 | ||
Crispr Therapeutics | Common | H17182108 | 231 | 3,800 | SH | DFND | 3,800 | 0 | 0 | ||
Common | 30303M102 | 1,745 | 8,500 | SH | DFND | 8,500 | 0 | 0 | |||
Homology Medicines | Common | 438083107 | 207 | 10,000 | SH | DFND | 10,000 | 0 | 0 | ||
Immuron Limited | Warrants | 45254U101 | 389 | 107,101 | SH | DFND | 107,101 | 0 | 0 | ||
Ishares Gold Trust | ETF | 464285105 | 1,624 | 112,000 | SH | DFND | 112,000 | 0 | 0 | ||
Mylan NV | Common | N59465109 | 3,520 | 175,100 | SH | DFND | 175,100 | 0 | 0 | ||
Novocure | Common | G6674U108 | 843 | 10,000 | SH | DFND | 10,000 | 0 | 0 | ||
SPDR Financial ETF | ETF | 81369Y605 | 262 | 8,500 | SH | DFND | 8,500 | 0 | 0 | ||
SPDR S&P 500 ETF | ETF | 78462F103 | 386 | 1,200 | SH | DFND | 1,200 | 0 | 0 | ||
SPDR Gold Shares ETF | ETF | 78463V107 | 643 | 4,500 | SH | DFND | 4,500 | 0 | 0 | ||
Vereit | Common | 92339V100 | 18,249 | 1,975,000 | SH | DFND | 1,975,000 | 0 | 0 |